# Selective Pulmonary-artery Intervention to Reduce Acute Right-heart tEnsion-II

Study · id `cardio:ct-nct06576427` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06576427](<https://clinicaltrials.gov/study/NCT06576427>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT06576427

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 123 participants.

## Technical summary

Registry record NCT06576427. Allocation not applicable; no masking; primary purpose treatment. Start 2024-10-15 (actual); primary completion 2026-02-04 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 123 participants (enrolled count; ClinicalTrials.gov record NCT06576427, source copy `cardio:ctgov-nct06576427-2026-04-06`, retrieved 2026-10-31)
- Started: 2024-10-15 (actual) (ClinicalTrials.gov record NCT06576427, source copy `cardio:ctgov-nct06576427-2026-04-06`, retrieved 2026-10-31)
- Primary completion: 2026-02-04 (actual) (ClinicalTrials.gov record NCT06576427, source copy `cardio:ctgov-nct06576427-2026-04-06`, retrieved 2026-10-31)
- Completion: 2026-03-03 (actual) (ClinicalTrials.gov record NCT06576427, source copy `cardio:ctgov-nct06576427-2026-04-06`, retrieved 2026-10-31)
- Countries: United States; Austria; Poland; Switzerland (ClinicalTrials.gov record NCT06576427, source copy `cardio:ctgov-nct06576427-2026-04-06`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06576427-2026-04-06`, retrieved 2026-10-31)

## The registry's words

- Brief title: Selective Pulmonary-artery Intervention to Reduce Acute Right-heart tEnsion-II
- Acronym: SPIRARE II
- Condition: Pulmonary Embolism
- Intervention (Device): Vertex Pulmonary Embolectomy System
- Lead sponsor: Jupiter Endovascular
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Pulmonary embolism (`cardio:pulmonary-embolism`)

## Provenance

Content hash: c6247c04f170ca2ea7c5a8d7388f0d6d5877b30da00a384d480d2857312948d2
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
